-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

Benzinga·08/11/2026 13:16:11
Listen to the news
Piper Sandler analyst Matt O'Brien reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight and raises the price target from $9 to $10.